Inference by interference: Task-dependent pupil responses as an early detection method for Alzheimer's disease related brainstem functional change
Inference by interference: Task-dependent pupil responses as an early detection method for Alzheimer's disease related brainstem functional change
批准号:
10805667
负责人:
Joost Riphagen
金额:
$42.64万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2025-09-29
关键词:
AffectAgeAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmyloidAmyloid beta-ProteinAnimal ModelAttentionAuditoryBehavioralBiological MarkersBrainBrain StemBrain regionCarbon DioxideCellsCerebellumClinicalCognitionCognitiveDetectionDiagnosisEarly DiagnosisEquilibriumFemaleFire - disastersFutureGoalsHealthHumanHyperactivityImageImpaired cognitionIndividualInterventionLearningLifeLimbic SystemMagnetic Resonance ImagingMeasuresMissionModelingMorphologyMydriasisNeocortexNeurofibrillary TanglesNeuronsParticipantPathologicPathologyPatternPersonsPhasePhenotypePhysiologicalPlayPopulation InterventionPopulations at RiskPositron-Emission TomographyPrevention trialPreventive treatmentProcessProxyPublic HealthPupilRattusReactionResearchRiskRoleShort-Term MemoryShortness of BreathSiteSpinal CordStressSupport SystemSymptomsSystemTarget PopulationsTestingTimeTreatment EfficacyUnited States National Institutes of HealthWorkcognitive processcognitive taskcognitive testingcohortdetection methodexecutive functionimprovedin vivoinclusion criteriainnovationinsightlocus ceruleus structuremiddle ageneocorticalneuron lossneuronal patterningnorepinephrine systemnovelpreventrecruitresilienceresponsesample fixationsextau Proteinstau aggregationtau expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Trials aimed at changing the hallmark proteinopathies of Alzheimer Disease (AD), Aβ and tau, have been
disappointing in halting or reducing cognitive decline. As these trials are often performed in symptomatic
individuals, where brain changes are irreversible, shifting interventions to asymptomatic individuals may be
more effective. The conundrum is to identify people who are more likely to be at risk of AD and who will benefit
from these interventions. While Aβ starts in the neocortex about 15 years before clinical symptoms, tau pathology
starts to accumulate from age 20 in the locus coeruleus (LC) before propagating towards the transenthorhinal
cortex, the limbic system and subsequently to the cortical regions. However, it is important to note that even
though by age 50, tau is omnipresent in the LC, not everyone will develop AD. Given that accumulation of tau in
the LC is associated with loss of projections, we posit that functional measures of the LC-Norepinephrine system
(LC-NE) may be more sensitive to distinguish individuals at-risk from those who are likely to maintain cognitive
health. The LC-NE system plays an important modulatory role in behavioral and cognitive processes including
‘executive’ functions like attention and working memory. The overall goal of the proposed project is to
detect the earliest AD related changes through read-outs related to LC function, which will
ultimately contribute to improved identification of the target population for interventions and
increase the efficacy of these interventions. LC neuronal function is characterized by tonic (that we can
elicit by increasing CO2) and phasic firing patterns (that can be elicited by novelty). Changes in pupil dilation
receive contributions from the LC-NE system, and by providing specific cognitive task loads, phasic and tonic LC
function can be derived. Wehypothesize that the pupil response in a task reacting to new tones after
a short breath hold vs no breath hold can be a biomarker of very early AD-related processes. We
will test these hypotheses in a group of clinically normal individuals (age range 55-80 years, n=70, 50% female)
leveraging to an ongoing deeply phenotyped cohort (SerialMK) that already collects Aβ and tau-PET imaging.
The results of this proposed project will contribute to improved detection of individuals at-risk by determining
(Aim 1): To investigate the tonic-phasic balance in pupil responses in different task settings (oddball, and oddball
after breath hold) and their relation to age and sex. (Aim 2): Relating pupillary responses in these different task
settings to AD pathology. The proposed research is innovative as it aims to identify at-risk populations in a non-
invasive, functionally relevant manner, using a readout of one of the earliest affected brain systems and thereby
opening up the opportunity to benefit prevention trials at a time in life when pathology is not yet extensive.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: